Pennsylvania Directory

Semaglutide Providers in Pennsylvania

GLP1Search tracks 330 Semaglutide provider records across 62 Pennsylvania cities. Use this page to compare provider density, source-quality signals, public pricing coverage, and local markets before contacting a clinic.

Provider Records

330

Cities

62

Source-Verified

0

Public Pricing

61

Medication Market Snapshot

Semaglutide access signals in Pennsylvania

Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management care. In the GLP1Search directory, the strongest Pennsylvania city clusters for Semaglutide are Philadelphia (208), Bryn Mawr (12), King of Prussia (11), Newtown Square (6). Directory records show 97% data completeness, 18% public-pricing coverage, and 0% source-verified listings for this state-medication segment.

Data Complete

97%

Pricing Visible

18%

Source Verified

0%

Top Pennsylvania cities for Semaglutide

Featured Semaglutide provider records in Pennsylvania

Patient Updates

Get new Semaglutide listings for Pennsylvania

Join the GLP1Search update list for provider additions, pricing changes, and source-quality notes in this market.

No spam. Unsubscribe anytime.

Clinic Claim

Claim or update a Pennsylvania listing

Clinics can submit Semaglutide availability, pricing, source details, clinical oversight, and contact information for review.

Claim Provider Listing

Provider submissions go through GLP1Search review before publishing.

All Pennsylvania cities with Semaglutide listings

Questions about Semaglutide providers in Pennsylvania

How many providers are listed?

GLP1Search lists 330 Semaglutide provider records across 62 cities in Pennsylvania.

Which cities have the most listings?

Philadelphia (208), Bryn Mawr (12), King of Prussia (11), Newtown Square (6), Bala Cynwyd (5) currently have the highest Semaglutide listing density in Pennsylvania.

Are brand examples the same as availability?

No. Ozempic, Wegovy, and Rybelsus are brand examples associated with Semaglutide. Actual availability depends on the clinic, prescription eligibility, insurance, pharmacy sourcing, and current regulatory status.